Dr Gail Darlington

Consultant Physician & Rheumatologist

MB BS MD FRCP

Specialty

Personal profile

Dr Darlington is a Consultant Physician and Rheumatologist with specialist accreditation in General Medicine and Rheumatology and an Honorary Consultant Physician at Epsom General Hospital, Surrey.

She graduated from Charing Cross Hospital Medical School, London University and received her Doctorate on lipid and purine metabolism in gout. She has been awarded the Hospital’s Trustees’ Research Fellowship, the Michael Mason Medal for her work on ultrasound in Rheumatology and a Private Patients’ Plan Research Fellowship at Jesus College, Cambridge.

She is a Fellow of the Royal College of Physicians and Honorary Senior Research Fellow at the University of Glasgow.

Primary care links Dr Darlington works closely with Primary Care colleagues and runs “telephone clinics” for patients to reach her directly and for Primary Care colleagues to discuss difficult problems.

She sees patients referred by GPs on a “one visit” basis to advise on a particular diagnostic or treatment problem before returning patients to the care of their GP.

She works with GP colleagues to transfer care of stable Rheumatology patients to the community, following UK Government’s requirements.

Research Dr Darlington has a widely-ranging research programme on rheumatoid arthritis, osteoporosis, gout, stroke, Huntington’s Disease, depression, chronic brain injury, Parkinson’s Disease, neuroprotection, lipid and purine metabolism, malaria, flavonoids in medicine and various aspects of nutritional immunology.

She founded Epsom Medical Research, a Registered Charity, and collaborates with Professor Trevor Stone at Glasgow University to combine clinical medicine and laboratory science.

Dr Darlington has published over 50 papers or reviews in peer-reviewed journals and has written four chapters and co-edited three books.

Professional Membership



  • Fellow: Royal College of Physicians

  • Member: British Medical Association

  • Member: British Society for Rheumatology

  • Member: British Society for Immunology

  • Member: International Society for Tryptophan Research

Clinical Interests



  • Assessment of complex/problematic rheumatologicical and medical patients

  • Monitoring of Disease-Modifying AntiRheumatic Drugs (DMARDs)e.g. methotrexate, leflunomide, mycophenolate, hydroxychloroquine,  sulphasalazine, etc.

  • Assessment of patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis to determine whether they need to be referred for biologic therapies (i.e. anti -TNF and B cell ablating therapies—infliximab, etanercept, adalimumab, rituximab, etc, it is helpful both for Primary and Secondary Care and for patients if pre-assessment can be provided in the Community, allowing Secondary Care colleagues to see patients when they have been correctly assessed

  • A full osteoporosis programme including correct use of bisphosphonates, (including zoledronate infusions), strontium, teriparatide etc. and the management of pain from osteoporotic fractures

  • Post-bereavement counselling

  • Working with primary care colleagues

Want to look at other consultants?